Cypriot rhythmic gymnastics judge Evangelia Trikomiti has been banned for four years for manipulating scores at the European Championships in May last year to ensure her compatriot qualified for the ...
Truist Securities reiterated its Buy rating and $60.00 price target for Protagonist Therapeutics (NASDAQ:PTGX) shares, which currently trade at $38.78 with a market capitalization of $2.3 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback